Vanda Pharmaceuticals
VNDA
#8812
Rank
NZ$0.38 B
Marketcap
NZ$6.30
Share price
-6.13%
Change (1 day)
-31.49%
Change (1 year)

EPS for Vanda Pharmaceuticals (VNDA)

EPS in 2026 (TTM): NZ-$8.04

According to Vanda Pharmaceuticals's latest financial reports the company's current EPS (TTM) is NZ-$8.45. In 2025 the company made an earnings per share (EPS) of NZ-$6.82 a decrease over its 2024 EPS that were of NZ-$0.58.

EPS history for Vanda Pharmaceuticals from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$8.0417.92%
2025NZ-$6.821065.63%
2024NZ-$0.58-710.9%
2023NZ$0.09575-56.35%
2022NZ$0.22-80%
2021NZ$1.10
2019NZ$3.97334%
2018NZ$0.91-247.06%
2017NZ-$0.62-19.05%
2016NZ-$0.77-55.32%
2015NZ-$1.72-347.37%
2014NZ$0.69-156.72%
2013NZ-$1.22-31.63%
2012NZ-$1.79

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$12.21-244.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$9.60-213.64%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$1.30-115.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$56.47-768.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$1.82-121.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$8.26-197.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
NZ-$8.02-4.98%๐Ÿ‡บ๐Ÿ‡ธ USA